Striverdi Respimat (olodaterol) is indicated for the long-term treatment of patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema, who are experiencing airflow obstruction.
What is COPD?
COPD (chronic obstructive pulmonary disease) affects the airways within the lungs, making it harder to breathe, and can get worse as time goes on. There are two forms of COPD: chronic bronchitis and emphysema. Many people who smoke or use to smoke are affected by COPD; however, it can also be due to exposure to pollution, chemical fumes, or dust.
There are several types of long-term or maintenance medications available to help you breathe better and improve lung function–Striverdi is the newest maintenance inhaler option.
What are some side effects of Striverdi Respimat?
The most common side effects include nasopharyngitis (AKA the common cold) or other upper respiratory tract infection, urinary tract infection, dizziness, rash, diarrhea, back pain, and joint pain.
What type of medication is Striverdi Respimat and how does it work?
Striverdi Respimat is a long-acting beta2-adrenergic agonist (LABA). LABAs work by relaxing the muscle of the airways within the lungs, which leads to easier breathing.
Can you use Striverdi Respimat on an as-needed basis?
NO. This is a once-daily maintenance medication that will need to be used whether you think you need it or not.
Which other medications are indicated for the long-term treatment of COPD?